Published in Clin Chem Lab Med on April 01, 1998
Preventing postoperative complications in the elderly. Anesthesiol Clin (2011) 0.98
Future suicide attempt and responses to serotonergic challenge. Neuropsychopharmacology (2008) 0.85
Pre-analytic considerations for the proper assessment of hormones of the hypothalamic-pituitary axis in epidemiological research. Eur J Epidemiol (2006) 0.81
Impact of music therapy on breast milk secretion in mothers of premature newborns. J Clin Diagn Res (2015) 0.79
Diurnal variation of cortisol in people with dementia: relationship to cognition and illness burden. Am J Alzheimers Dis Other Demen (2011) 0.77
Selective use of peri-operative steroids in pituitary tumor surgery: escape from dogma. Front Endocrinol (Lausanne) (2013) 0.77
Stress reactivity to an electronic version of the Trier Social Stress Test: a pilot study. Front Psychol (2015) 0.77
Neonatal intensive care and child psychiatry inpatient care: do different working conditions influence stress levels? Nurs Res Pract (2013) 0.77
Born to yawn? Understanding yawning as a warning of the rise in cortisol levels: randomized trial. Interact J Med Res (2012) 0.76
The Effects of Sex Hormonal Fluctuations during Menstrual Cycle on Cortical Excitability and Manual Dexterity (a Pilot Study). PLoS One (2015) 0.75
ACTH, Cortisol and IL-6 Levels in Athletes following Magnesium Supplementation. J Med Biochem (2016) 0.75
Cortisol in saliva--reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem (1995) 1.73
Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med (1994) 1.69
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients. Br J Clin Pharmacol (1984) 1.53
Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism. Acta Med Scand (1979) 1.49
Controlled study of atenolol in treatment of hypertension. Br Med J (1975) 1.41
A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol. Eur J Clin Pharmacol (1976) 1.21
Neuroendocrine response in acute heart failure and the influence of treatment. Eur Heart J (1989) 1.16
Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome. Eur J Clin Pharmacol (1989) 1.12
Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J Neural Transm (1979) 1.00
Glycemic control and prognosis in type I diabetic patients with microalbuminuria. Diabetes Care (1996) 0.98
Once-daily metoprolol in primary hypertension. Clin Pharmacol Ther (1979) 0.97
Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. J Hypertens (1994) 0.95
Prizidilol, an antihypertensive with precapillary vasodilator and beta-adrenoceptor blocking actions, in primary hypertension. Clin Pharmacol Ther (1981) 0.94
Membrane transport of L-triiodthyronine by human red cell ghosts. Biochem Biophys Res Commun (1979) 0.92
Relationships between blood pressure, age, plasma renin activity and electrolyte excretion in normotensive subjects. Scand J Clin Lab Invest (1977) 0.91
Atrial natriuretic peptide in pregnant and lactating goats. Acta Endocrinol (Copenh) (1989) 0.91
Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake. J Cardiovasc Pharmacol (1985) 0.91
Plasma and urinary aldosterone and their interrelations with blood pressure, plasma renin activity and urinary electrolytes in normotensive subjects. Scand J Clin Lab Invest (1978) 0.90
Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent. Acta Med Scand (1976) 0.90
Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity. Acta Med Scand (1981) 0.89
Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study. Hypertension (1980) 0.88
Uptake of L-triiodothyronine into human cultured lymphocytes. Acta Endocrinol (Copenh) (1980) 0.87
Cyclic adenosine 3',5'-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyper- and hypothyroidism. J Clin Endocrinol Metab (1974) 0.87
A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest Suppl (1984) 0.86
Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes. Diabetes Care (2001) 0.86
Facial palsy in diabetes mellitus--not only a mononeuropathy? Adv Otorhinolaryngol (1977) 0.85
Renin concentrations and effects of propranolol and spironolactone in patients with hypertension. Br Med J (1976) 0.85
Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs. J Cardiovasc Pharmacol (1994) 0.85
Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report. Scand J Urol Nephrol Suppl (1984) 0.85
Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension. Eur J Clin Pharmacol (1985) 0.84
Increased bronchial reactivity and potentiated skin responses in hypertensive subjects suffering from coughs during ACE-inhibitor therapy. Chest (1989) 0.84
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. Am J Vet Res (1996) 0.84
Triodothyronine and thyroxine nuclear receptors in lyphocytes from normal, hyper- and hypothyroid subjects. Acta Endocrinol (Copenh) (1977) 0.83
Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy. Diabet Med (1998) 0.83
Thyroid hormones and the adrenergic nervous system. Acta Med Scand Suppl (1983) 0.83
An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure. Scand J Clin Lab Invest (1998) 0.82
Long-term effects of captopril and atenolol in essential hypertension. Acta Med Scand (1985) 0.82
Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels. Am J Vet Res (1994) 0.81
Physiological cortisol substitution of long-term steroid-treated patients undergoing major surgery. Br J Anaesth (1981) 0.81
Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity. Am J Cardiol (1976) 0.81
The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status. Blood Press (1997) 0.81
Prostaglandin E2, renin and angiotensin II in renovascular hypertension. J Hypertens (1984) 0.81
Mitogenic activity of glia maturation factor. Interaction with insulin and insulin-like growth factor-II. Exp Cell Res (1985) 0.80
An exploration of intrapulmonary insulin administration in anaesthetized and mechanically ventilated pigs. Scand J Clin Lab Invest (1996) 0.80
Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity. Acta Med Scand (1979) 0.80
Circulatory effects of noise. Acta Med Scand (1983) 0.80
Effect of coffee on ambulatory blood pressure in patients with treated hypertension. J Intern Med (1993) 0.80
Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone. Curr Ther Res Clin Exp (1977) 0.80
Population-based reference values for IGF-I and IGF-binding protein-1: relations with metabolic and anthropometric variables. Eur J Endocrinol (1997) 0.79
Effects of intrapulmonary insulin in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest (1996) 0.79
Long-term experience of captopril in the treatment of primary (essential) hypertension. Br J Clin Pharmacol (1982) 0.79
The pharmacology of zimelidine: a 5-HT selective reuptake inhibitor. Acta Psychiatr Scand Suppl (1981) 0.79
Human lymphocyte binding and deiodination of thyroid hormones in relation to thyroid function. Acta Endocrinol (Copenh) (1975) 0.79
Effects of in vitro addition of captopril on copper-induced low density lipoprotein oxidation. Br J Clin Pharmacol (1995) 0.79
Plasma concentrations of angiotensin II and aldosterone during acute left ventricular failure in the dog. Effect of converting enzyme inhibition. Res Exp Med (Berl) (1986) 0.79
Intrapulmonary administration of insulin to healthy volunteers. J Intern Med (1996) 0.79
Acute tolerance to furosemide. Pretreatment with captopril or prazosin does not influence diuresis and natriuresis. Scand J Urol Nephrol (1994) 0.79
Salivary cortisol and serum prolactin in relation to stress rating scales in a group of rescue workers. Biol Psychiatry (1999) 0.78
Effects of oestrogens, orchidectomy and cyproterone acetate on salt and water metabolism in carcinoma of the prostate. Eur Urol (1981) 0.78
A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome. Blood Press (1996) 0.78
Timolol and hydrochlorothiazide-amiloride in primary hypertension. Clin Pharmacol Ther (1980) 0.78
Plasma catecholamines and cardiovascular responses to hypoglycemia in hyperthyroidism before and during treatment with metoprolol or propranolol. J Clin Endocrinol Metab (1980) 0.78
Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementia. J Neural Transm (1984) 0.78
Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs. Am J Vet Res (1997) 0.78
Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes. Ann Clin Res (1983) 0.77
Cortisol, growth hormone and prolactin responses to insulin-induced hypoglycaemia in hyperthyroid patients before and during beta-adrenoceptor blockade. Clin Endocrinol (Oxf) (1980) 0.77
Prizidilol (SKF 92657) in primary hypertension. Clin Sci (Lond) (1981) 0.77
Captopril, aldosterone and urinary kallikrein in primary hypertension. Clin Exp Hypertens A (1983) 0.77
The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes. J Renin Angiotensin Aldosterone Syst (2000) 0.77
Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication. J Intern Med (1992) 0.77
Early post-operative growth hormone levels predict the result of transsphenoidal tumour removal in acromegaly. Acta Endocrinol (Copenh) (1983) 0.77
Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat. Neurosci Lett (1981) 0.77
Hypertension in pregnancy. Prostaglandins, kinins and kallikrein. Scand J Clin Lab Invest Suppl (1984) 0.77
Twenty-four hour ambulatory blood pressure in the population. J Intern Med (1996) 0.76
Changes in the renin-angiotensin-aldosterone and kallikrein-kinin systems during normal and hypertensive pregnancy. Acta Obstet Gynecol Scand Suppl (1984) 0.76
Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin-angiotensin system. J Hum Hypertens (1997) 0.76
Adrenergic regulation of renin release and effects on angiotensin and aldosterone. Acta Med Scand Suppl (1983) 0.76
Whole-body cooling increases plasma endothelin-1 levels in women with primary Raynaud's phenomenon. Clin Physiol (1998) 0.76
A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives. Acta Med Scand (1984) 0.76
Anti-aggressive effect of zimelidine in isolated mice. Acta Pharmacol Toxicol (Copenh) (1980) 0.76
Studies on the role of central 5-HT neurons in avoidance learning: a behavioral and biochemical analysis. Adv Exp Med Biol (1981) 0.75
Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function. J Clin Pharmacol (1990) 0.75
Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system. Acta Endocrinol (Copenh) (1982) 0.75
Treatment of endogenous depression with oral thyrotropin-releasing hormone and amitriptyline. Acta Psychiatr Scand (1978) 0.75
Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure. Br J Clin Pharmacol (1982) 0.75
Newer concepts in the therapy of hypertension. Angiology (1978) 0.75
Angiotensin II in primary hypertension, relationship to plasma renin activity, aldosterone and urinary electrolytes. Acta Med Scand (1979) 0.75
Plasma renin activity, aldosterone and sodium excretion in women with high and low casual blood pressure levels. Acta Med Scand (1978) 0.75
Salmon calcitonin in the acute treatment of moderate and severe hypercalcemia in man. Acta Med Scand (1978) 0.75
5-Hydroxytryptamine and avoidance performance in the rat. Antagonism of the acute effect of p-chloroamphetamine by zimelidine, an inhibitor of 5-hydroxytryptamine uptake. Neurosci Lett (1978) 0.75
Age, blood pressure, renin and urinary electrolytes in primary hypertension and in the normotensive state. Scand J Clin Lab Invest (1978) 0.75
Antihypertensive effect of atenolol--a Swedish multicentre study. Postgrad Med J (1977) 0.75
Clinical evaluation of atenolol in hypertension. Clin Sci Mol Med Suppl (1976) 0.75
[Iodine deficiency--still a reality?]. Lakartidningen (1974) 0.75
[Clinical testing of a new beta blocking agent--atenolol--in hypertension]. Lakartidningen (1976) 0.75
Thyroid nodule autonomy: its demonstration by the thyrotrophin releasing hormone (TRH) stimulation test. Acta Endocrinol (Copenh) (1973) 0.75
Clinical experience with the thyrotrophin releasing hormone (TRH) stimulation test in patients with thyroid, pituitary and hypothalamic disorders. Acta Endocrinol (Copenh) (1973) 0.75